A Randomized, Open-Label, Phase I, Single-Dose Study of Antisense Oligonucleotide, Vupanorsen, in Chinese Adults with Elevated Triglycerides.
Xiaojie WuJicheng YuBeikang GeJeffrey WangXiaoran HanChunye ZhangXiaomeng MaoHindu KalluruCandace BramsonSteven G TerraJing LiuPublished in: Drugs in R&D (2024)
ClinicalTrials.gov identifier: NCT04916795.